pSivida Corp

Press Releases

All Releases
View Summary pSivida Corp. Strengthens Board of Directors With Leading Ophthalmologist
Sep 27, 2016
PDF 18.2 KB Add to Briefcase
View Summary pSivida to Present at the Ladenburg Thalmann Annual Healthcare Conference
Sep 22, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Reports Inducement Awards to New President and Chief Executive Officer
Sep 20, 2016
PDF 14.0 KB Add to Briefcase
View Summary pSivida Implements Leadership Change -- Nancy Lurker Named as President and CEO
Sep 15, 2016
PDF 18.7 KB Add to Briefcase
View Summary pSivida Corp. Provides Company Update and Reports Fourth Quarter and FY 2016 Results
Sep 12, 2016
PDF 37.8 KB Add to Briefcase
View Summary pSivida Corp. Announces Fourth Quarter and Fiscal Year 2016 Financial Results Release Date and Conference Call Information
Sep 1, 2016
PDF 14.1 KB Add to Briefcase
View Summary pSivida Announces 13 New Patents Issued or Allowed
Aug 29, 2016
PDF 17.4 KB Add to Briefcase
View Summary Topline Results from First Phase 3 Trial of pSivida's Medidur™ Presented at ASRS Annual Meeting
Aug 15, 2016
PDF 18.3 KB Add to Briefcase
View Summary Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
Aug 9, 2016
PDF 18.3 KB Add to Briefcase
View Summary pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer
Aug 3, 2016
PDF 16.9 KB Add to Briefcase
View Summary pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Aug 1, 2016
PDF 24.0 KB Add to Briefcase
View Summary pSivida's Medidur™ Maintains Same High Statistical Significance in Primary Endpoint through 12 Months in First Phase 3 Trial (p Less Than 0.00000001)
Jul 27, 2016
PDF 22.2 KB Add to Briefcase
View Summary Data Shows pSivida's Tethadur™ Provides Prolonged, Sustained Release of Avastin® With High Drug Efficacy
Jul 20, 2016
PDF 19.4 KB Add to Briefcase
View Summary pSivida Corp. Announces Plan to Consolidate all Research and Development in Current U.S. Facility
Jul 15, 2016
PDF 16.8 KB Add to Briefcase
View Summary Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve
Jul 14, 2016
PDF 20.2 KB Add to Briefcase
View Summary pSivida Announces Poster and Oral Presentation on Controlled Release of Avastin® from Tethadur™ Biodegradable Matrix at the 2016 Controlled Release Society Annual Meeting
Jul 8, 2016
PDF 16.7 KB Add to Briefcase
View Summary pSivida Announces Successful Completion of Two Preclinical Studies of Durasert™ Sustained-Release Insert Delivering Repurposed Cancer Drug to Treat Wet AMD
Jul 5, 2016
PDF 18.3 KB Add to Briefcase
View Summary pSivida Corp. Provides Company Update and Reports Third Quarter FY 2016 Results
May 5, 2016
PDF 34.6 KB Add to Briefcase
View Summary pSivida CEO to Present at 2016 International Symposium of Ocular Pharmacology and Therapeutics
May 4, 2016
PDF 16.4 KB Add to Briefcase
View Summary pSivida's Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe
May 2, 2016
PDF 17.4 KB Add to Briefcase
Showing 21-40 of 282 Page: 1 2 3 4 5 6 ... 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Search Investor Relations

pSivida